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Introduction: Breast cancer is a global health problem with 2.09 million cases of breast cancer diagnosed
worldwide in 2018. With an increase in breast cancer survival attention has now focussed on the impact
treatment side effects can have on the quality of life for women during survivorship. The aim of the
SuPPORT 4 All project is to develop a support bra for use during radiotherapy, that can reduce normal
tissue toxicity (for women with larger breasts) and provide accuracy, dignity and modesty for all women.
The first stage of the project involved a co-design process to understand the current patient experience
where no support bra or modesty device is used.
Method: A participatory co-design methodology was adopted. Workshops were held with patient rep-
resentatives (n ¼ 9) to seek understanding of experience during radiotherapy; a total of three workshops
over 4 h. The workshops were audio recorded and framework analysis was adopted to identify key
patient experiences.
Results: Twelve categories and twenty-six sub categories were identified specific to patient experience.
Patient concerns focussed on information provision, Healthcare Practitioner (HCP) knowledge of breast
lymphoedema, lack of choice, experiences of being naked, and feelings of disempowerment.
Conclusions: A number of areas were identified that had negative effects on overall patient experience.
Implications for practice: Practitioners should consider patient dignity when configuring services to
support patient needs regarding undressing, outside or inside the linear accelerator room. Additionally,
practitioners should have an understanding of the impact permanent tattoos may have on some patients’
wellbeing and the impact that breast lymphoedema has on patient quality of life. Practitioners should
also consider methods to encourage patient empowerment during radiotherapy; supporting patient self-
monitoring of side-effects may be one way to facilitate this.
© 2020 The College of Radiographers. Published by Elsevier Ltd. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).5,6 7,Introduction
Breast cancer is a global health problem with 2.09 million cases
of breast cancer diagnosed worldwide in 2018,1 accounting for
11.6% of all cancer incidence. Survival from breast cancer has
improved in many countries, with over 1 million women surviving
the disease in 2012.2 Hence as more women survive, attention has
now focussed on the impact treatment related side effects and
treatment experiences can have on the quality of life for women
and their ability to cope during survivorship.
There has been significant research in the field of breast irra-
diation techniques over recent years to reduce treatment related
sequela.3,4 The experience of involvement in clinical trials such as, Sheffield Hallam University,
ished by Elsevier Ltd. This is an ope
bottom, H. Crank et al., The
tudy, Radiography, https://doHeartSpare (I and II) and the IMPORT trials means many
radiotherapy departments are moving to more complex radio-
therapy techniques including Intensity Modulated Radiotherapy
(IMRT), and the use of breath hold techniques, or implementing
simultaneous integrated boost techniques; some of these tech-
niques enable greater lung and heart sparing.
However, there has been less research investigating patients'
experiences of the delivery of radiotherapy. There is a range of
research that focusses on patient's lived experiences of a breast
cancer diagnosis, perceptions of treatment and experiences of
survivorship or assessments of symptoms from radiotherapy.8e13
However, the research tends to focus primarily on information
needs, or frequency or experience of side effects. There is little focus
on the experience of attending for breast irradiation itself.
Schnur et al. (2009) reported on the assessment of patient diary
reflections written during a course of breast irradiation (14) (n¼ 15
women). The key themes identified in this qualitative studyn access article under the CC BY license (http://creativecommons.org/licenses/by/4.
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i.org/10.1016/j.radi.2020.09.011
H. Probst, K. Rosbottom, H. Crank et al. Radiography xxx (xxxx) xxxfocussed on timing (for example timing of side effects), health after
treatment, self-esteem and the mysteriousness of radiotherapy and
how it works.14 However, there was no indication or discussion of
the impact permanent tattoos may have on patient experience and
limited discussion of the impact wearing gowns or being naked
might have on patients’ overall treatment experience.
For example, in the majority of radiotherapy centres worldwide
women lie for breast irradiation bare from the waist upwards, with
up to four therapy radiographers (Radiation Therapists) including
students and men adjusting and manipulating their thorax and
breast in preparation for treatment. Many women are known to
have body image concerns following breast surgery15,16 and the
manipulation required to position the breast for treatment can be
undignified. In one study body image scores measured using the
four body image questions from the European Organisation for
Research and Treatment for Cancer questionnaire (EORTC QLQ
Br23) identified patients on active treatment (radiotherapy or
chemotherapy) may have significantly worse body image than
patients that are post-treatment (6 months post treatment) or
women in the general population without a history of breast can-
cer.16 Body image scores were 47.5 vs 53.4 and 70.2 for those on
active treatment, post-treatment and controls respectively, where
higher scores reflect a more positive body image. Hence, patients
may be at their most vulnerable in terms of low body image when
they attend for radiotherapy, and at a time when they are asked to
lie naked in front of healthcare workers.
In addition, most radiotherapy centres rely on the use of at least
three permanent tattoos (but it can be more) marked on the pa-
tient; the use of permanent tattoos can be a concern to some pa-
tients17 and may have an impact on body image.18 In addition, a
range of practices occur across radiotherapy centres in terms of
physical undress in waiting rooms and in the linear accelerator
room itself. The use of gowns or how undressing is managed19 can
vary, with potential effects on dignity and modesty or emotional
experiences.20
The primary aim of the SuPPORT 4 All project was to design,
produce and test a support bra for women undergoing breast
irradiation. In the development stage of the project we aimed to
determine current experiences of radiotherapy for breast cancer.
Specifically, we wanted to determine answers to the following
questions:
1. What are women's experiences of the radiotherapy pathway
from radiation planning to completion of a full treatment
course?
2. What are women's views of being naked (from the waist up-
wards) during planning and treatment sessions?
3. How do permanent tattoos affect the overall patient
experience?
These questions were relevant to how we approached the
design of a bra support device.
Methodology and method
The Medical Research Council (MRC) framework for complex
interventions21 was adopted for the SuPPORT 4 All study; this stage
of the study presented here represents the development phase of
the MRC framework. To gather stakeholder insights, we designed a
series of workshops (five in total) (Fig. 1). A participatory co-design
method22 was adopted as this method offered the opportunity for
co-interpretation of design refinements by the researchers and the
eventual users of the bra; both patients and healthcare practi-
tioners, specifically therapy radiographers (also known as Radia-
tion Therapists or RTTs), and physicists or dosimetrists. The2
participatory co-design approach ensures participants’ in-
terpretations are embodied in the developing design and that the
resultant product is shaped through a joint (researcher and par-
ticipants) vision.
The participatory co-design process involved three key
elements:
1. Understanding the process and the patient experience.
2. Clarification of user goals and expectations of the final product
and
3. Iterative shaping of the bra technology detail.
The focus of the results presented here is on understanding the
process and the patient experience (element 1) above.
Recruitment and selection of subjects
Sampling was purposive; we were keen to discuss experiences
of breast irradiation with women that had undergone radiotherapy
to the breast within the last five years. We approached a local
support group for cancer patients to request assistance with
reaching individuals that met the following criteria:
 Diagnosed with breast cancer,
 Undergone conservative surgery (wide local excision leaving an
intact breast), and
 Had experienced radiotherapy as part of the treatment package.
The local support centre invited us to present details of the
study to centre staff, who agreed to mention the study to relevant
individuals who attended the centre. We also had individuals that
volunteered to join the co-design workshops as they had heard
about our study through other contacts. All participants signed a
consent form prior to attending. As the design of the support bra
was to be discussed in the workshops all participants were also
asked to sign a confidential non-disclosure agreement to protect
details of the bra design.
Details of the setting, data collection process, workshop modera-
tors and facilitators can be found in the Supplementary material (S1)
Pre-workshop preparation
Prior to attendance participants were sent a link to a Cancer
Research UK short video on breast radiotherapy23; this served to
simply remind participants of their own radiotherapy experience.
In addition, participants were also asked to annotate a diagram-
matic presentation of the radiotherapy pathway (see Fig. 2) with
details of their experiences at each point in the pathway. It was
explained to participants that these would be discussed in the first
co-design workshop.
Data analysis
The transcribed data was imported into NVivo software
(version10) and analysed independently by A1 and A2 using
framework analysis. Framework analysis is a well-used technique
for organising and charting qualitative data in health research.24
The researchers familiarised themselves with the data by reading
and re-reading the transcripts and playing back the audio re-
cordings. Coding followed a line by line open coding process. A set
of codes were identified by each researcher (A1, A2) fromworkshop
1 and compared. Discussion of the two independent code lists led
to a single analytical framework fromwhich a set of themes and sub
themes were derived.
Figure 1. A diagrammatic presentation of the Co-Design process.
Figure 2. Pre-workshop preparation, the radiotherapy pathway participants were asked to annotate.
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A number of techniques were used to minimise opportunities
for bias (see Supplementary materials 1 for more detail). It was
important the research findings were regulated through the
participant's lens,25 as this is central to the co-design method-
ology. Member-checking was used within and after the work-
shops to ensure the participants' voice (not the researchers) was
presented.26 Member-checking is a process of confirming that3
data analysis has captured the participants original intended
meaning and is important for ensuring credibility of the
outcomes.
Ethics approval
The Health and Social Care research ethics committee of the
Host Institution gave ethical approval for the study; all participants
were recruited outside the National Health Service (NHS).
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Nine patient representatives attended the first, third and fourth
co-design workshops (see Fig. 1). Of those participants that con-
sented to participate none dropped out of the study. Time since
radiotherapy for each participant ranged from less than one year to
five years. Across all workshops (workshop one to five in Fig. 1) the
first data analysis by A1 and A2 independently identified 131
separate codes. Following discussion these codes were refined and
condensed to fourteen categories and ninety-six sub-categories in
total. Table 1 identifies the twelve categories and twenty-six sub-
categories related specifically to patient experience of radio-
therapy; the remaining two categories were feedback on the bra
design and challenges to delivering breast irradiation from HCPs.
The findings are reported according to the three principle
questions driving the stakeholder engagement workshops:
1. What are women's experiences of the radiotherapy pathway
from radiation planning to completion of a full treatment
course?
2. What are women's views of being naked (from the waist up-
wards) during planning and treatment sessions?
3. How do permanent tattoos affect the overall patient
experience?Women's experiences of the radiotherapy pathway
Information needs
Participants’ discussions highlighted some deficiencies in the
provision of information that affected the overall patient
experience.
Some participants had specific questions that were not
answered (see Fig. 3 and the Supplementary material S2.1.1)
There seemed to be a lack of personalisation of information that
was provided and “it just seemed to be that this is the protocol; this is
what we're doing”Table 1
Categories and codes specific to patient experience of the radiotherapy journey.
Categories identified from user discussions Sub Categories




Exposure Issues of Modesty
Wearing a gown in a publ
Emotional experience Feeling embarrassed
Interactions with HCPs Staff attitudes
Feeling a burden
Finding your voice Being listened to Disempo




Having to have tattoos
Fear Fear about treatment accu
Feeling frightened
The waiting room experience Inappropriate entertainm
Getting to radiotherapy Physically getting there to
The emotional journey-w
Impact of side effects Skin reactions
Finding a comfortable bra
The changed self Lost self confidence
Change to personal image
Wanting to feel normal
4
The timing of information was important for participants; one
reported receiving an information leaflet containing all the de-
tails about treatment side effects after she had signed the con-
sent form (rather than before) and she became alarmed at the
potential side effects having already signed and given her con-
sent to proceed. While another participant, received an infor-
mation leaflet that had been photocopied and the quality was
poor, the images were difficult to see and the words were a bit
“wonky”.
Many of the study participants had developed breast lym-
phoedema during or after radiotherapy and most were unprepared
for this happening (Fig. 3).Emotional experience
Participants commented on the emotional impact of attending
for radiotherapy. Often radiotherapy is seen and spoken of as the
easy part of the breast cancer treatment pathway; often pro-
moted by radiographers as ‘the easy bit’. In fact, participants
found their radiotherapy experience difficult in ways they were
not expecting. In their words they found it ‘impersonal’, and
‘dehumanising’, they felt ‘vulnerable’ and ‘disempowered’ (see
Fig. 4).Women's views of being naked
Exposure
Discussions about being exposed included experiences both
inside and outside of the linear accelerator room. Participants
commented about the negative experience of having to wait in
draughty corridors dressed in a hospital gown as well as the
experience of being undressed while in the treatment room. There
was also comment about how wearing a gown affected the dy-
namics of the waiting room experience, how easy or difficult it was
to make conversation while wearing a gown and not your normal
clothes (see Fig. 5).ic place
wered




hat has come before (including chemotherapy, surgery the end of a long process)
to wear during the radiotherapy period
/body image
Figure 3. Information needs.
Figure 4. Emotional experiences-coping through radiotherapy.
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While patients understood the need for accuracy and achieving
the best outcomes, they struggled to maintain dignity throughout
the radiotherapy process. Experiences of waiting for treatment in
waiting rooms and the need to be quick once in the treatment room
meant patients were either required to sit in the waiting room in a
gown (without a bra) or wear their own clothes, but for speed go
braless (Fig. 6).
There were also comments about the number of people in
the room during planning and treatment sessions and the
knowledge that teaching was going on with lots of people
present and this added to the feelings of vulnerability lack of5
modesty and difficulty to maintain dignity (Fig. 5). Feelings of
loss of dignity were also compounded by a sense of loss of the
‘self’; the person they used to be, and the control that they
used to have over their lives.
“I felt stripped of myself somehow and really disempowered.”
(S2.1.2)
The impact of tattoos on the patient experience
Tattoos are currently seen as the gold standard for aligning pa-
tients for breast irradiation. Women in our stakeholder workshops
Figure 5. Exposure.
Figure 6. Dignity and modesty, and the impact of permanent tattoos.
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about the use of tattoos, and whether they had a choice to have
them or not. While a few women didn't mind having the tattoos
“it's fine it's nothing”. Others had often-profound experiences that
were linked to other experiences in the radiotherapy journey such
as lack of choice, disempowerment and realisation that what they
had was not a small insignificant disease but something bigger;6
something that required a permanent mark as a reminder and
marker of the enormity of the cancer condition.
Discussion
The results highlighted some agreement with previous research
but also identified some new insights on the patient experience of
H. Probst, K. Rosbottom, H. Crank et al. Radiography xxx (xxxx) xxxthe breast cancer radiotherapy pathway; these are discussed under
the key areas of inquiry.
Women's experiences of the radiotherapy pathway
Provision of information has been shown to decrease emotional
distress, and enhance self-care strategies.27 Long (2001) in a qual-
itative study of twenty patients with different cancer diagnoses
identified the importance of information provision in giving pa-
tients a sense of control and was significant in a patient's ability to
cope during radiotherapy. Feeling prepared was important for in-
dividuals in Long's study as was the timing of information and this
was identified in our study also. Seeking information has been
shown to be a coping mechanism particularly for younger breast
cancer patients.28
Schnur et al. (2009) studied women's experiences (n ¼ 15) of
radiotherapy through personal diaries.14 Four key themes were
highlighted; timing was one theme. However, unlike the present
study timing was primarily related to when symptoms occurred
rather than timing of information. Yet Schnur et al. (2009) conclude
that the way information is presented to patients about when
symptoms are likely to start (and end) maybe critical for how pa-
tients subsequently react to symptoms as they occur.
A clear message emerged fromhalf of theworkshop participants
that breast lymphoedema was poorly communicated to them, and
getting their concerns heard by HCPs was problematic. Breast
lymphoedema appears silenced in the literaturewith an abundance
of research on arm lymphoedema29,30 but very limited research on
breast lymphoedema31; focusing on quantifying incidence with
little emphasis on understanding the patient experience.
Emotional experience
Women commented on the emotional ‘drain’ associated with
attending for radiotherapy and how ‘dehumanising’ the whole
process was. These words reflect the whole process including
waiting room experiences, in-room linear accelerator (Linac) ex-
periences and interactions with healthcare staff. Mose et al.
(2001)32 identified a significant correlation between these external
factors (waiting room, linac room perceptions) and radiotherapy
associated anxiety (p < 0.02) and while they do not reflect causa-
tion it is reasonable to assume that good waiting room and Linac
room experiences may positively reduce radiotherapy associated
anxiety. The experience of lying alone on a CT scanner or Linac
couch while HCPs focus on set-up parameters and patient align-
ment may exacerbate patient feelings of technology-focussed
rather than patient focussed care during planning and treatment
procedures; this contrasts with the human contact and attention
received during chemotherapy.
The experience of being naked following breast conserving surgery
It is known that women who have undergone breast surgery
experience issues with altered body image.15,33 What is less clear is
the impact of having to lie naked on a bed from the waist upwards
when already experiencing an altered body image, or wearing a
gown in public waiting areas.
Exposure
The experience of lying naked for radiotherapy treatment is
rarely discussed in the research literature; it remains the domain of
personal blogs from cancer survivors. Yet it was recognised twenty
years ago as being problematic for women.19 Harris and Haas
(1997) developed a modesty gown for women to wear during
breast irradiation (the Plymouth Gown), during evaluation (n¼ 20)7
seventy percent of women indicated feeling self-conscious about
their body at the time; 86% preferred using the gown for treatment.
Modesty and dignity
Despite the initial success of the Plymouth gown uptake across
radiotherapy centres has been limited; due in part to differences
across centres in the use of positioning marks. Some women have
reported that the gown identifies them inwaiting rooms as a breast
cancer patient; while other patients sit in their own clothes indis-
tinguishable from carers.20 Women in our study found the use of a
gown to partially cover them during treatment exposure (providing
modesty for the unaffected breast) was often distracting and led to
some anxiety when the gown started to slip. Apart from these two
studies on the breast gown19,20 attention to the experience of
women lying naked for breast irradiation is absent in the literature.
Use of permanent tattoos
We are aware from previous research17 that there are mixed
views about the use of permanent tattoos for breast radiotherapy
positioning. There are currently limited skin marking alternatives
to the use of permanent black tattoos; although the use of ultra-
violet tattoos provide a possible option for some women.18 How-
ever, in the study by Landeg et al. (2016) the UV tattoos were not
successful on sub-Saharan skin tones. There was some indication
that body image post radiotherapy maybe enhanced as a result of
using UV tattoos (56% of those with UV tattoos reported improve-
ments in body image score at one month, compared with only 14%
in the black ink tattoo group). However, median body image scores
were consistent from baseline to one-month post treatment for the
UV tattoo patients, improving by only 1.0 by six months. In the
black ink tattoo group median body image scores from baseline to
six months increased by only 0.5; differences in median scores at
six months was not statistically significant.18
There is currently limited clinical experience of using UV tattoos
for breast irradiation and for some patients the fact they are still
permanent and will be visible under black lighting conditions, may
make them an unattractive option. For the women in our study the
issue surrounding the use of permanent tattoos was closely linked
to a lack of choice. Principally participants felt they had little or no
optionwhen it came to having permanent tattoos; despite evidence
that careful use of semi-permanent ink (for those that prefer this
option) produces equivalent random and systematic errors.17
Study limitations
The research presented here is from a small sample of women, it
is not intended to be reflective of the experiences of breast irradi-
ation for all women. However, it does provide insight in to the
experiences of a few and to highlight areas of practice where HCPs
can make small improvements that could enhance experience.
Conclusions and next steps
This small scale participatory co-design study highlighted a
number of areas where it may be possible to improve the patient
experience of radiotherapy to the breast. It has confirmed the
importance of good quality information and attention to the timing
of information giving. Specifically, this study has identified poten-
tial gaps in HCP knowledge and understanding of breast lym-
phoedema, added further concern about the impact of using
permanent black tattoos and insight in to patient dignity regarding
undressing and exposure outside or inside the linear accelerator
room. This study has highlighted a number of areas of new
knowledge including patient experiences of disempowerment that
H. Probst, K. Rosbottom, H. Crank et al. Radiography xxx (xxxx) xxxcan hamper opportunities for a fast recovery and return to normal
activities or work. Opportunities for patients to be involved in self-
monitoring of symptomsmay reduce these experiences. To this end
we have co-designed two self-monitoring tools for patients to
complete during radiotherapy to monitor skin changes and the
development changes in the breast that may be indicative of breast
lymphoedema.
Data Sharing
Due to the consent process for participants the qualitative
research data is not available for sharing.
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